Skip to main content
SpringerLink
Log in

Imaging of Neuropsychiatric Systemic Lupus Erythematosus

  • Chapter
  • First Online:
Neuropsychiatric Systemic Lupus Erythematosus

  • 617 Accesses

Abstract

The diagnosis of neuropsychiatric manifestations in systemic lupus erythematosus (NPSLE) is challenging. Neuroimaging is very important technique for the evaluation of abnormalities occurred in the central nervous system (CNS). Computed tomography (CT) scan is one of the common techniques and is very useful to detect a large lesion such as ischemic stroke, hemorrhage and tumor, providing help to rule out CNS diseases other than SLE. Magnetic resonance imaging (MRI) is the best tool at present to detect parenchymal lesions in the CNS. Conventional MRI figures out exact abnormalities in the CNS causing neurologic or psychiatric symptoms. However, it should be remembered that MRI abnormalities in patients with NPSLE are not always specific for NPSLE. New MRI techniques can give us more detailed information in patients with NPSLE in addition to findings by conventional MRI. Functional analysis of the CNS by imaging system would be promising.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ainiala H, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45:419–23.

    Article  CAS  PubMed  Google Scholar 

  2. Bertsias GK, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69:2074–82.

    Article  CAS  PubMed  Google Scholar 

  3. Chang Y-S, et al. Increased risk of subarachnoid hemorrhage in patients with systemic lupus erythematosus: a nationwide population-based study. Arthritis Care Res (Hoboken). 2013;65:601–6.

    Article  CAS  Google Scholar 

  4. Mimori A, et al. Subarachnoid hemorrhage and systemic lupus erythematosus. Lupus. 2000;9:521–6.

    Article  CAS  PubMed  Google Scholar 

  5. Liang MH, et al. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.

    Article  Google Scholar 

  6. Raymond AA, et al. Brain calcification in patients with cerebral lupus. Lupus. 1996;5:123–8.

    Article  CAS  PubMed  Google Scholar 

  7. Nordstrom DM, West SG, Andersen PA. Basal ganglia calcifications in central nervous system lupus erythematosus. Arthritis Rheum. 1985;28:1412–6.

    Article  CAS  PubMed  Google Scholar 

  8. Anderson JR. Intracerebral calcification in a case of systemic lupus erythematosus with neurological manifestations. Neuropathol Appl Neurobiol. 1981;7:161–6.

    Article  CAS  PubMed  Google Scholar 

  9. Sibbitt WL, et al. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum. 2010;40:32–52.

    Article  PubMed  Google Scholar 

  10. Luyendijk J, et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum. 2011;63:722–32.

    Article  CAS  PubMed  Google Scholar 

  11. Steup-Beekman GM, et al. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause. Ann Rheum Dis. 2013;72(Suppl 2):ii76–9.

    Article  CAS  PubMed  Google Scholar 

  12. Karassa FB, et al. Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med. 2000;109:628–34.

    Article  CAS  PubMed  Google Scholar 

  13. Sanna G, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus. 2000;9:573–83.

    Article  CAS  PubMed  Google Scholar 

  14. Appenzeller S, et al. Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients. Ann Neurol. 2008;64:635–43.

    Article  PubMed  Google Scholar 

  15. McCune WJ, et al. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum. 1988;31:159–66.

    Article  CAS  PubMed  Google Scholar 

  16. Sibbitt WL, et al. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1999;42:2026–38.

    Article  PubMed  Google Scholar 

  17. Harris EN, et al. Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol. 1985;8:251–66.

    Article  CAS  PubMed  Google Scholar 

  18. Arinuma Y, et al. Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Lupus Sci Med. 2014;1:e000050.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Castellino G, et al. Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement. Rheumatology (Oxford). 2008;47:319–23.

    Article  CAS  Google Scholar 

  20. Walecki J, et al. MR in neurological syndromes of connective tissue diseases. Med Sci Monit. 2002;8:MT105–11.

    PubMed  Google Scholar 

  21. Moritani T, et al. Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus. Acad Radiol. 2001;8:741–53.

    Article  CAS  PubMed  Google Scholar 

  22. Bosma GPT, et al. Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus. AJNR Am J Neuroradiol. 2003;24:850–4.

    PubMed  Google Scholar 

  23. Hjort N, et al. Ischemic injury detected by diffusion imaging 11 minutes after stroke. Ann Neurol. 2005;58:462–5.

    Article  PubMed  Google Scholar 

  24. Roldan CA, et al. Libman-sacks endocarditis and embolic cerebrovascular disease. JACC Cardiovasc Imaging. 2013;6:973–83.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ellison D, et al. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol. 1993;46:37–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Brooks WM, et al. The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 2010;62:2055–63.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Arinuma Y, et al. Histopathological analysis of cerebral hemorrhage in systemic lupus erythematosus complicated with antiphospholipid syndrome. Mod Rheumatol. 2011;21:509–13.

    Article  PubMed  Google Scholar 

  28. Tono T, et al. Transverse myelitis extended to disseminated encephalitis in systemic lupus erythematosus: histological evidence for vasculitis. Mod Rheumatol. 2016;26:958–62.

    PubMed  Google Scholar 

  29. De Boysson H, et al. Primary angiitis of the central nervous system: description of the first fifty-two adults enrolled in the french cohort of patients with primary vasculitis of the central nervous system. Arthritis Rheumatol. 2014;66:1315–26.

    Article  PubMed  Google Scholar 

  30. Boerma C, et al. An acute multiorgan thrombotic disorder associated with antiphospholipid antibodies; two “catastrophic” cases. Ann Rheum Dis. 1997;56(9):568.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Boura P, et al. Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case. Clin Rheumatol. 2005;24(4):420.

    Article  PubMed  Google Scholar 

  32. Magro Checa C, et al. Demyelinating disease in SLE: is it multiple sclerosis or lupus? Best Pract Res Clin Rheumatol. 2013;27:405–24.

    Article  PubMed  Google Scholar 

  33. Wingerchuk DM, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85:177–89.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Mader S, et al. Understanding the antibody repertoire in neuropsychiatric systemic lupus erythematosus and neuromyelitis optica spectrum disorders: do they share common targets? Arthritis Rheumatol (Hoboken, NJ). 2017. doi:https://doi.org/10.1002/art.40356.

  35. Merayo-Chalico J, et al. Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study. J Neurol Neurosurg Psychiatry. 2016;87:287–94.

    Article  PubMed  Google Scholar 

  36. Hugonnet E, et al. Posterior reversible encephalopathy syndrome (PRES): features on CT and MR imaging. Diagn Interv Imaging. 2013;94:45–52.

    Article  CAS  PubMed  Google Scholar 

  37. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11:906–17.

    Article  PubMed  Google Scholar 

  38. Dasgupta N, et al. Central nervous system lymphoma associated with mycophenolate mofetil in lupus nephritis. Lupus. 2005;14:910–3.

    Article  CAS  PubMed  Google Scholar 

  39. Tsang HHL, et al. Diffuse large B-cell lymphoma of the central nervous system in mycophenolate mofetil-treated patients with systemic lupus erythematosus. Lupus. 2010;19(3):330.

    Article  CAS  PubMed  Google Scholar 

  40. Svobodova B, et al. Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil. Lupus. 2011;20:1452–4.

    Article  CAS  PubMed  Google Scholar 

  41. Sibbitt WL, et al. Fluid Attenuated Inversion Recovery (FLAIR) imaging in neuropsychiatric systemic lupus erythematosus. J Rheumatol. 2003;30:1983–9.

    PubMed  Google Scholar 

  42. Raina A, et al. Cerebral white matter hyperintensities on MRI and acceleration of epigenetic aging: the atherosclerosis risk in communities study. Clin Epigenetics. 2017;9:21.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jeong HW, et al. Brain MRI in neuropsychiatric lupus: associations with the 1999 ACR case definitions. Rheumatol Int. 2015;35:861–9.

    Article  CAS  PubMed  Google Scholar 

  44. Appenzeller S, et al. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum. 2005;52(9):2783.

    Article  PubMed  Google Scholar 

  45. Kozora E, et al. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1998;41:41–7.

    Article  CAS  PubMed  Google Scholar 

  46. Appenzeller S, et al. Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus. NeuroImage. 2007;34:694–701.

    Article  PubMed  Google Scholar 

  47. Ainiala H, et al. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol. 2005;34:376–82.

    Article  CAS  PubMed  Google Scholar 

  48. Coan AC, et al. Quantification of hippocampal signal intensity in patients with mesial temporal lobe epilepsy. J Neuroimaging. 2003;13:228–33.

    Article  PubMed  Google Scholar 

  49. Appenzeller S, et al. Hippocampal atrophy in systemic lupus erythematosus. Ann Rheum Dis. 2006;65:1585–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Lapa AT, et al. Abnormality in hippocampal signal intensity predicts atrophy in patients with systemic lupus erythematosus. Lupus. 2017;26:633–9.

    Article  CAS  PubMed  Google Scholar 

  51. Sanchez-Garcia M, et al. Hypertrophic pachymeningitis associated with cerebral spinal fluid hypovolemia as initial presentation of systemic lupus erythematous. Lupus. 2014;23:197–200.

    Article  PubMed  Google Scholar 

  52. Han F, et al. Cranial and lumbosacral hypertrophic pachymeningitis associated with systemic lupus erythematosus: a case report. Medicine (Baltimore). 2016;95:e4737.

    Article  Google Scholar 

  53. Guillen-Del Castillo A, et al. Increased myo-inositol in parietal white and gray matter as a biomarker of poor prognosis in neuropsychiatric lupus: a case report. Lupus. 2014;23:1073–8.

    Article  CAS  PubMed  Google Scholar 

  54. Huizinga TW, et al. Imaging modalities in central nervous system systemic lupus erythematosus. Curr Opin Rheumatol. 2001;13:383–8.

    Article  CAS  PubMed  Google Scholar 

  55. Sibbitt WL, et al. Neuropsychiatric systemic lupus erythematosus. Compr Ther. 1999;25:198–208.

    Article  PubMed  Google Scholar 

  56. Brooks WM, et al. Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol. 1999;26:81–5.

    CAS  PubMed  Google Scholar 

  57. Alexander AL, et al. Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains. Brain Connect. 2011;1:423–46.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Costallat BL, et al. Brain diffusion tensor MRI in systematic lupus erythematosus: a systematic review. Autoimmun Rev. 2018;17:36–43.

    Article  PubMed  Google Scholar 

  59. Bosma GP, et al. Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. Arthritis Rheum. 2000;43:48–54.

    Article  CAS  PubMed  Google Scholar 

  60. Bosma GP, et al. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging. Arthritis Rheum. 2000;43:2428–36.

    Article  CAS  PubMed  Google Scholar 

  61. Emmer BJ, et al. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dy. Arthritis Rheum. 2008;58:1451–7.

    Article  CAS  PubMed  Google Scholar 

  62. Magro-Checa C, et al. Changes in white matter microstructure suggest an inflammatory origin of neuropsychiatric systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ). 2016;68:1945–54.

    Article  CAS  Google Scholar 

  63. Saito T, et al. Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder. J Neurol Sci. 2017;379:127–30.

    Article  CAS  PubMed  Google Scholar 

  64. Mackay M, et al. Brain metabolism and autoantibody titres predict functional impairment in systemic lupus erythematosus. Lupus Sci Med. 2015;2:e000074.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology and Infectious diseases, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan

    Yoshiyuki Arinuma

  2. Department of Rheumatology, Nobuhara Hospital, Tatsuno, Hyogo, Japan

    Shunsei Hirohata

  3. Department of Rheumatology & Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan

    Shunsei Hirohata

Authors
  1. Yoshiyuki Arinuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shunsei Hirohata
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Rheumatology, Nobubara Hospital, Tatsuno, Hyogo, Japan

    Shunsei Hirohata

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Arinuma, Y., Hirohata, S. (2018). Imaging of Neuropsychiatric Systemic Lupus Erythematosus. In: Hirohata, S. (eds) Neuropsychiatric Systemic Lupus Erythematosus. Springer, Cham. https://doi.org/10.1007/978-3-319-76496-2_8

Download citation

Publish with us

Policies and ethics

Search

Navigation